RareResearch.AI
← Back to atlas

C537Y

Category 3/4 — Most DruggableUncertain significanceTransmembrane · predictedSource card
CysteineTyrosine at position 537 · Transmembrane helix 8 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type C537 — hydrogen bond to C541
Fullscreen ↗
DynaMut2 mutant · C537Y
Mutant Y537 — hydrogen bond contact to Y444 lost
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

0 lost14 gained11 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondT440Gained
Hydrogen bondY444Y444Preserved
Hydrogen bondP533P533Preserved
Hydrogen bondY534Y534Preserved
Hydrogen bondW540W540Preserved
Hydrogen bondC541C541Preserved
Polar contactT440Gained
Polar contactY444Gained
Polar contactL459Gained
Polar contactP533P533Preserved
Polar contactY534Y534Preserved
Polar contactL535L535Preserved
Polar contactW540W540Preserved
Polar contactC541C541Preserved
Aromatic / πY444Gained
CarbonylY534Gained
Van der WaalsT440Gained
Van der WaalsY534Gained
Van der WaalsL535Gained
Van der WaalsC541Gained
HydrophobicT440Gained
HydrophobicY444Gained
HydrophobicL447L447Preserved
HydrophobicL459Gained
HydrophobicY534Gained

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-1.43kcal/mol
Destabilising — moderate
AlphaMissense
0.986
likely pathogenic
AlphaFold pLDDT
90
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsInborn genetic diseases; Monogenic diabetes; Cataract 41; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram syndrome 1; Wolfram-like syndrome
Population frequency (gnomAD v4)Ultra-rare · AF 0.0057%
cDNA changec.1610G>A
ClinVar accessionVCV000215390
Last evaluated2025/12/26 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — C537Y Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Cysteine → Tyrosine at position 537. Transmembrane helix 8. ClinVar Uncertain significance, AlphaMissense 0.986, DynaMut2 ΔΔG -1.43 kcal/mol (destabilising).


Identity

FieldValue
VariantC537Y (p.Cysteine537Tyrosine)
DNA changec.1610G>A
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV000215390
Amino acid changeCysteine (C) → Tyrosine (Y)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 53789.50 — well-folded
DomainTransmembrane helix 8
Position contextInside Transmembrane helix 8 · position 537 is bilayer-embedded
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 537 sits in a transmembrane helix (Transmembrane helix 8). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is thiol (cysteine — disulfide-capable, free -SH); the mutant is aromatic with hydroxyl (tyrosine — H-bond donor/acceptor). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.9858
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)-1.43 (Destabilising)
Job ID178092090125
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092090125

Clinical Evidence

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, multiple submitters, no conflicts
Last evaluated2025/12/26 00:00
InheritanceAutosomal dominant pattern indicated by associated DFNA6/14/38 (WFS1 hearing loss 6).
WFS1 variant landscapeC537Y is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)
  • Inborn genetic diseases
  • Monogenic diabetes
  • Cataract 41
  • Autosomal dominant nonsyndromic hearing loss 6
  • Type 2 diabetes mellitus
  • Wolfram syndrome 1
  • Wolfram-like syndrome

Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=1.43 < 2 kcal/mol (fold intact) + AlphaMissense 0.986 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=1.43 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.986. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • C537Y_molstar_viewer.html — interactive 3D viewer (auto-highlights position 537 with ball-and-stick + neighbors within 5Å)
  • C537Y_variant_card.md — this card (source of truth)
  • C537Y_variant_card.html — styled printable card
  • C537Y_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • C537Y_wildtype_interactions.pse / C537Y_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the C537Y PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download C537Y PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.